Tabuk Pharmaceuticals signs license and supply agreement with Selectchemie
Source: PRNewswire , Author: Posted by BI-ME staff
Posted: Fri October 6, 2017 11:56 am

JORDAN. -- /PRNewswire/ -- Tabuk Pharmaceutical Manufacturing Company ("Tabuk"), one of the leading pharmaceutical companies in the Middle East and North Africa (MENA) region, has entered into an agreement with Selectchemie, under which Selectchemie granted Tabuk a license to register, market and sell Caspofungin Injection (systemic antifungal agent) in Saudi Arabia, the Gulf Countries, North Africa, and the rest of Middle East.

Selectchemie is one of the leading European companies, headquartered in Zurich serving the pharmaceutical and human nutrition industries since 1969 as a premier supplier of high quality ingredients.

Dr. Rana Azzam, Senior VP of Business Development said "We are excited about this major partnership collaboration with Selectchemie. Caspofungin Injection is a hard to develop and lifesaving product. This partnership will provide an opportunity for both companies to leverage their combined strength."

Selectchemie side commented "Dr. Peter Kaufmann, CEO of Selectchemie, is proud to have gained Tabuk Pharmaceutical Manufacturing Company as a licensing and marketing partner for Caspofungin in the MENA Region. With this highest quality product, manufactured in Europe, Selectchemie looks forward to a long-term partnership with Tabuk to the benefit of both companies and end-users."

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: December 10, 2017
UAE. Declining reserves and revenues, along with rising domestic energy demand, require a shift to enable performance and sustainability.
date:Posted: December 9, 2017
UAE. Recent geopolitical developments on the regional front and new residential legislation in Dubai are both likely to impact the emirate's property market. 
date:Posted: December 9, 2017
INTERNATIONAL. Now's the time for a bold, forward-thinking company to stand up and challenge the new, established way of accepting everyone's ideas as equally valid.
dhgate